I’m with you 100% mate. I don’t disagree with the high figures,...

I’m with you 100% mate. I don’t disagree with the high figures, I’ve read through the posts where the numbers are crunched and the triangle report it all makes sense - but I just can’t wrap my head around how realistic (achievable) some of it is. Once bisantrene is on the world stage again in trials (220) and journals there will without doubt be a lot of external interest, if that data is solid external parties won’t sit on their hands - if they do I’d be seriously concerned about my holding. Luckily I don’t think that.

I’m very comfortable with DT and Pete’s leadership therefore I’m buying now every chance I get as funds allow. Yes im arguably taking on more risk but I’m happy with the level of risk. My plan is to take a core holding to buyout/endgame etc but as we break milestones I think it’s realistic to expect people will start to unwind their positions in portions to derisk which is why I think taking a modest approach to figures is sensible, anything extra is a bonus! FYI modest to me is $10+ as unpopular as this will be.